To further determine whether GBA might be responsible for the inhibitory effects of ART in HCC cell malignancy, the GBA activator LTI-291 (10 nM) was used in combination with ART (20 μM, 0.5 IC50). The gene discussed is GBA1; the disease is hepatocellular carcinoma.